Kevin Fischbeck
Stock Analyst at B of A Securities
(4.01)
# 598
Out of 5,005 analysts
183
Total ratings
65.38%
Success rate
6.21%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $20.53 | -12.32% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $131.16 | +6.74% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $203.00 | +10.84% | 7 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $123.23 | +29.84% | 2 | Sep 10, 2025 | |
| HUM Humana | Maintains: Neutral | $285 → $312 | $283.72 | +9.97% | 16 | Sep 2, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $290 → $325 | $360.20 | -9.77% | 26 | Aug 18, 2025 | |
| ARDT Ardent Health | Downgrades: Underperform | $16 → $15 | $14.02 | +4.14% | 3 | Jul 16, 2025 | |
| CNC Centene | Downgrades: Underperform | $52 → $30 | $38.70 | -22.48% | 13 | Jul 16, 2025 | |
| UHS Universal Health Services | Downgrades: Underperform | $215 → $185 | $207.24 | -10.73% | 15 | Jul 16, 2025 | |
| HCA HCA Healthcare | Downgrades: Neutral | $394 → $410 | $429.54 | -4.55% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $33 | $27.14 | +21.59% | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $1.13 | +165.49% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $646 → $530 | $350.50 | +51.21% | 3 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $201.97 | +117.36% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.09 | -28.49% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $16.62 | -56.38% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $311.00 | +12.54% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $21.15 | +112.77% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.12 | +76.28% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $12.93 | +170.69% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.59 | +286.10% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $13.17 | -43.05% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $27.50 | -34.55% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $17.50 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $34.87 | -45.51% | 2 | Feb 9, 2018 |
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $20.53
Upside: -12.32%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $131.16
Upside: +6.74%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $203.00
Upside: +10.84%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $123.23
Upside: +29.84%
Humana
Sep 2, 2025
Maintains: Neutral
Price Target: $285 → $312
Current: $283.72
Upside: +9.97%
UnitedHealth Group
Aug 18, 2025
Maintains: Neutral
Price Target: $290 → $325
Current: $360.20
Upside: -9.77%
Ardent Health
Jul 16, 2025
Downgrades: Underperform
Price Target: $16 → $15
Current: $14.02
Upside: +4.14%
Centene
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $38.70
Upside: -22.48%
Universal Health Services
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $207.24
Upside: -10.73%
HCA Healthcare
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $429.54
Upside: -4.55%
May 13, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $27.14
Upside: +21.59%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $1.13
Upside: +165.49%
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $350.50
Upside: +51.21%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $201.97
Upside: +117.36%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.09
Upside: -28.49%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $16.62
Upside: -56.38%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $311.00
Upside: +12.54%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $21.15
Upside: +112.77%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.12
Upside: +76.28%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $12.93
Upside: +170.69%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.59
Upside: +286.10%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $13.17
Upside: -43.05%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $27.50
Upside: -34.55%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $17.50
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $34.87
Upside: -45.51%